Since low RKIP expression in primary tumors was also a strong positive predictive factor for breast cancer recurrences [17, 30], we examined the prognostic value of different MMP13/RKIP expression combinations in breast cancers in which the expression of MMP13, RKIP and clinical outcome are available in published microarray expression data set. The gene discussed is MMP13; the disease is breast cancer.